Noninvasix Overview
- Year Founded
-
2007
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$2M
- Investors
-
17
Noninvasix General Information
Description
Developer of an optoacoustic platform technology designed to non-invasively and continuously measure central venous saturation. The company's technology specializes in monitoring the severity of sepsis and septic shock non-invasively to diagnose and monitor the response to treatment of tissue hypoxia in real-time, enabling clinicians to more quickly and accurately diagnose critically ill patients and tailor treatments to improve outcomes.
Contact Information
Website
www.noninvasix.comCorporate Office
- 301 University Boulevard
- Galveston, TX 77555
- United States
Corporate Office
- 301 University Boulevard
- Galveston, TX 77555
- United States
Noninvasix Timeline
Noninvasix Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 16. Later Stage VC | 03-Jul-2024 | $2M | Completed | Generating Revenue | ||
| 15. Later Stage VC (Series A) | 24-Apr-2023 | Completed | Pre-Clinical Trials | |||
| 14. Accelerator/Incubator | 01-Jan-2023 | Completed | Pre-Clinical Trials | |||
| 13. Later Stage VC | 06-May-2022 | Completed | Pre-Clinical Trials | |||
| 12. Seed Round | 18-Feb-2021 | Completed | Product Development | |||
| 11. Seed Round | 10-Jun-2020 | Completed | Product Development | |||
| 10. Angel (individual) | 07-Jan-2019 | Completed | Startup | |||
| 9. Grant | 05-Aug-2018 | Completed | Startup | |||
| 8. Accelerator/Incubator | 30-Nov-2016 | Completed | Startup | |||
| 7. Accelerator/Incubator | 28-Sep-2016 | Completed | Startup |
Noninvasix Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed 3 | ||||||||
| Seed 2 | ||||||||
| Seed 1 | 332,618 | $0.001000 | $1.02 | $1.02 | 1x | $1.02 | 3.4% | |
| Seed | 1,716,051 | $0.001000 | $1.22 | $1.22 | 1x | $1.22 | 17.53% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Noninvasix Comparisons
Industry
Financing
Details
Noninvasix Competitors (1)
One of Noninvasix’s competitors is ICU Medical, a Corporation company based in San Clemente, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| ICU Medical | Corporation | San Clemente, CA |
Noninvasix Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Noninvasix Patents
Noninvasix Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240130709-A1 | Sequential adaptor for combined ultrasound and optoacoustic diagnostic interrogation of the left innominate vein | Pending | 16-Jun-2021 | ||
| EP-4355219-A1 | Sequential adaptor for combined ultrasound and optoacoustic diagnostic interrogation of the left innominate vein | Pending | 16-Jun-2021 | ||
| EP-4221574-A1 | Using an optical energy meter to normalize acoustic response signals for accurate calculation of blood oxygenation | Pending | 29-Sep-2020 | ||
| US-20230233088-A1 | Using an optical energy meter to normalize acoustic signals generated by laser pulses of various wavelengths to permit accurate calculation of blood oxygenation | Pending | 29-Sep-2020 | ||
| EP-4221574-A4 | Using an optical energy meter to normalize acoustic response signals for accurate calculation of blood oxygenation | Pending | 29-Sep-2020 | A61B5/0095 |
Noninvasix Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Noninvasix Investors (17)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Rockies Venture Club | Venture Capital | Minority | ||
| Southwest National Pediatric Device Innovation Consortium | Accelerator/Incubator | |||
| Philips | Corporation | Minority | ||
| Green Park & Golf Ventures | Venture Capital | Minority | ||
| Philips North America Pension Plan | Limited Partner | Minority |
Noninvasix FAQs
-
When was Noninvasix founded?
Noninvasix was founded in 2007.
-
Where is Noninvasix headquartered?
Noninvasix is headquartered in Galveston, TX.
-
What is the size of Noninvasix?
Noninvasix has 4 total employees.
-
What industry is Noninvasix in?
Noninvasix’s primary industry is Monitoring Equipment.
-
Is Noninvasix a private or public company?
Noninvasix is a Private company.
-
What is Noninvasix’s current revenue?
The current revenue for Noninvasix is .
-
How much funding has Noninvasix raised over time?
Noninvasix has raised $10.1M.
-
Who are Noninvasix’s investors?
Rockies Venture Club, Southwest National Pediatric Device Innovation Consortium, Philips, Green Park & Golf Ventures, and Philips North America Pension Plan are 5 of 17 investors who have invested in Noninvasix.
-
Who are Noninvasix’s competitors?
ICU Medical is a competitor of Noninvasix.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
